Join
Live feed
·
PRReleasevia Quantisnow
Krystal Biotech Inc. logo
Palvella Therapeutics Inc. logo

Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services

ByQuantisnow·Wall Street's wire, on your screen.
KRYS· Krystal Biotech Inc.PVLA· Palvella Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRYS (Krystal Biotech Inc.), PVLA (Palvella Therapeutics Inc.) and more on Quantisnow.

Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services | Quantisnow